表观遗传改变与记忆:急性肾损伤和糖尿病促进慢性肾脏病发生发展的关键因素
急性肾损伤(AKI)幸存者进展为慢性肾脏病(CKD)的风险增加8.8倍、肾衰竭风险增加3.1倍,20%至40%的糖尿病患者会发展为糖尿病肾脏病(DKD)。高血糖和缺氧可诱导DNA甲基化、组蛋白翻译后修饰及非编码RNA等表观遗传记忆,这种记忆通常可逆,靶向表观遗传记忆在实验模型中可预防CKD发生发展。
要点
- AKI幸存者进展为CKD风险增加8.8倍,肾衰竭风险增加3.1倍。
- 20%至40%的糖尿病患者会发展为DKD。
- 表观遗传记忆通常可逆,靶向治疗在实验模型中有效。
核心结论
- 表观遗传记忆是AKI和糖尿病促进CKD发生发展的关键机制,靶向表观遗传记忆是潜在治疗途径。
研究设计与样本
- 综述,总结DKD和AKI中表观遗传特征及AKI向CKD转化或DKD发生发展中表观遗传记忆的最新深入证据。
主要发现
- AKI幸存者进展为CKD风险增加8.8倍,肾衰竭风险增加3.1倍。
- 20%至40%的糖尿病患者会发展为DKD。
- 高血糖和缺氧可诱导DNA甲基化、组蛋白翻译后修饰及非编码RNA等表观遗传记忆。
- 在AKI和DKD实验模型中,靶向表观遗传记忆的治疗策略可有效预防CKD发生发展。
临床怎么用
- 表观遗传记忆通常可逆,为改善高血糖和缺氧导致的持续疾病进展提供了治疗机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease (CKD) is a highly prevalent global public health issue and can progress to kidney failure. Survivors of acute kidney injury (AKI) have an increased risk of progressing to CKD by 8.8-fold and kidney failure by 3.1-fold. Further, 20% to 40% of individuals with diabetes will develop CKD, also known as diabetic kidney disease (DKD). Thus, preventing these kidney diseases can positively impact quality-of-life and life-expectancy outcomes for affected individuals. Frequent episodes of hyperglycemia and renal hypoxia are implicated in the pathophysiology of CKD. Prior periods of hyperglycemia/uncontrolled diabetes can result in development/progression of DKD even after achieving normoglycemia, a phenomenon known as metabolic memory or legacy effect. Similarly, in AKI, hypoxic memory is stored in renal cells even after recovery from the initial AKI episode and can transition to CKD. Epigenetic mechanisms involving DNA methylation, chromatin histone post-translational modifications, and noncoding RNAs are implicated in both metabolic and hypoxic memory, collectively known as "epigenetic memory." This epigenetic memory is generally reversible and provides a therapeutic avenue to ameliorate persistent disease progression due to hyperglycemia and hypoxia and prevent/ameliorate CKD progression. Indeed, therapeutic strategies targeting epigenetic memory are effective at preventing CKD development/progression in experimental models of AKI and DKD. Here, we review the latest in-depth evidence for epigenetic features in DKD and AKI, and in epigenetic memories of AKI-to-CKD transition or DKD development and progression, followed by translational and clinical implications of these epigenetic changes for the treatment of these widespread kidney disorders.
引用
- Mimura I, Chen Z, Natarajan R, et al. Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes. Kidney Int. 2024. PMID: 39725223. doi:10.1016/j.kint.2024.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。